Filing Flows › Comparisons › GIPL vs PAVM
Global Innovative Platforms vs PAVmed: GIPL and PAVM compared
Global Innovative Platforms is the larger company: $51K of revenue in its latest quarter (Q3 FY26) against $33K for PAVmed (Q2 2026).
Where the money goes: GIPL and PAVM
Global Innovative Platforms (GIPL) · Q3 FY26
Global Innovative Platforms, Q3 FY26: revenue $51K, operating margin -476.6%, net loss $242K, operating cash flow −$134K. The chart follows the revenue to costs, profit and cash.
PAVmed (PAVM) · Q2 2026
PAVmed, Q2 2026: revenue $33K (+450% year over year), net loss $6.6M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
| Global Innovative Platforms (GIPL) | PAVmed (PAVM) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $51K | $33K |
| Revenue growth, Y/Y | — | +450% |
| Operating margin | -476.6% | n/m |
| Net earnings | −$242K | −$6.6M |
| Net margin | -476.5% | — |
| Operating cash flow | −$134K | −$2.7M |
Questions
Which is bigger, Global Innovative Platforms or PAVmed?
Global Innovative Platforms is the larger company: $51K of revenue in its latest quarter (Q3 FY26) against $33K for PAVmed (Q2 2026).
More: Global Innovative Platforms earnings · how Global Innovative Platforms makes money · PAVmed earnings · how PAVmed makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.